Korea National Institute of Health and IVI announce MOU to “expedite research and development of vaccines for public use”

The Korea National Institute of Health and the International Vaccine Institute (IVI) announced a memorandum of understanding to “expedite research and development of vaccines for public use.” According to the MOU, the two organizations “will boost research cooperation in vaccine development, and strengthen and expand cooperation in diverse fields of interest, including:

– Development of vaccines against emerging or re-emerging infectious diseases with a public health purpose;

– Molecular epidemiological studies for vaccine development; and

– Sharing information and resources in the field of emerging and re-emerging infectious diseases.

The two organizations “expect strengthened cooperation between the two sides will generate synergistic effect in the field of vaccine R&D, and thus enable them to emerge as global centers of research, including in the development of next-generation vaccines.”

IVI Director-General Dr. Christian Loucq added, “IVI is very pleased to collaborate with KNIH on vaccine research projects and training initiatives, which will mutually benefit the two organizations as well as Korea’s vaccine R&D. More importantly, this collaboration will ultimately contribute to improving the health and well-being of people in Korea and worldwide.”